Aperio Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $2.52M | Buy |
14,548
+3,656
| +34% | +$633K | 0.01% | 1129 |
|
|
2020
Q3 | $1.21M | Sell |
10,892
-927
| -8% | -$103K | ﹤0.01% | 1348 |
|
|
2020
Q2 | $701K | Sell |
11,819
-3,418
| -22% | -$203K | ﹤0.01% | 1592 |
|
|
2020
Q1 | $1.03M | Buy |
15,237
+1,052
| +7% | +$70.8K | ﹤0.01% | 1293 |
|
|
2019
Q4 | $1.2M | Buy |
14,185
+252
| +2% | +$21.2K | ﹤0.01% | 1345 |
|
|
2019
Q3 | $1.04M | Buy |
13,933
+3,776
| +37% | +$282K | ﹤0.01% | 1371 |
|
|
2019
Q2 | $642K | Buy |
10,157
+1,684
| +20% | +$106K | ﹤0.01% | 1643 |
|
|
2019
Q1 | $408K | Buy |
8,473
+792
| +10% | +$38.1K | ﹤0.01% | 1861 |
|
|
2018
Q4 | $257K | Buy |
7,681
+2,113
| +38% | +$70.7K | ﹤0.01% | 2019 |
|
|
2018
Q3 | $292K | Buy |
+5,568
| New | +$292K | ﹤0.01% | 2025 |
|
|
2017
Q1 | – | Sell |
-20,503
| Closed | -$161K | – | 2153 |
|
|
2016
Q4 | $161K | Buy |
+20,503
| New | +$161K | ﹤0.01% | 2039 |
|